Bupivacaine liposome injectable suspension (Exparel)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Bupivacaine liposome injectable suspension (Exparel), covering 2024-05-23 to 2024-05-23. Get the full timeline:
Most recent: Clinical Trial Update: Effect of Bupivacaine Liposome Anterior Serratus Deep Block on Chronic Pain After Breast Cancer Surgery: a Randomized Controlled Study [NA]